Yuanfeng Gong

机构：Guangzhou Medical University Cancer Hospital, Guangzhou Medical University · ORCID：0000-0001-7742-6286

发表论文 66 篇 · 总被引 1451 次 · h-index 22

代表论文

• Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management (2020 · World Journal of Gastroenterology · 被引 205)
• Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate (2021 · Science Translational Medicine · 被引 81)
• Genome-Wide CRISPR/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma (2022 · International Journal of Biological Sciences · 被引 61)
• Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma (2023 · Cancer Imaging · 被引 53)
• Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma (2021 · Nature Communications · 被引 36)
• Knockdown of lncRNA ZNRD1-AS1 suppresses gastric cancer cell proliferation and metastasis by targeting the miR-9-5p/HSP90AA1 axis (2021 · Aging · 被引 26)